Immunogenicity of Externally Activated Nanoparticles for Cancer Therapy

dc.citation.articleNumber2559
dc.citation.issueNumber12
dc.citation.journalTitleCancers
dc.citation.volumeNumber12
dc.contributor.authorSahin, Onur
dc.contributor.authorMeiyazhagan, Ashokkumar
dc.contributor.authorAjayan, Pulickel M.
dc.contributor.authorKrishnan, Sunil
dc.date.accessioned2020-12-16T19:47:20Z
dc.date.available2020-12-16T19:47:20Z
dc.date.issued2020
dc.description.abstractNanoparticles activated by external beams, such as ionizing radiation, laser light, or magnetic fields, have attracted significant research interest as a possible modality for treating solid tumors. From producing hyperthermic conditions to generating reactive oxygen species, a wide range of externally activated mechanisms have been explored for producing cytotoxicity within tumors with high spatiotemporal control. To further improve tumoricidal effects, recent trends in the literature have focused on stimulating the immune system through externally activated treatment strategies that result in immunogenic cell death. By releasing inflammatory compounds known to initiate an immune response, treatment methods can take advantage of immune system pathways for a durable and robust systemic anti-tumor response. In this review, we discuss recent advancements in radiosensitizing and hyperthermic nanoparticles that have been tuned for promoting immunogenic cell death. Our review covers both preclinical and clinical results, as well as an overview of possible future work.
dc.identifier.citationSahin, Onur, Meiyazhagan, Ashokkumar, Ajayan, Pulickel M., et al.. "Immunogenicity of Externally Activated Nanoparticles for Cancer Therapy." <i>Cancers,</i> 12, no. 12 (2020) MDPI: https://doi.org/10.3390/cancers12123559.
dc.identifier.digitalcancers-12-03559-v2
dc.identifier.doihttps://doi.org/10.3390/cancers12123559
dc.identifier.urihttps://hdl.handle.net/1911/109734
dc.language.isoeng
dc.publisherMDPI
dc.rightsThis is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.keywordradiosensitizing nanoparticles
dc.subject.keywordX-ray
dc.subject.keywordrare-earth elements
dc.subject.keywordphotothermal therapy
dc.subject.keywordphotodynamic therapy
dc.subject.keywordmagnetic hyperthermia
dc.titleImmunogenicity of Externally Activated Nanoparticles for Cancer Therapy
dc.typeJournal article
dc.type.dcmiText
dc.type.publicationpublisher version
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
cancers-12-03559-v2.pdf
Size:
1.88 MB
Format:
Adobe Portable Document Format